OverviewSuggest Edit

Ginkgo Bioworks is a company that designs, engineers, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria to protect the body from dangerous infections and generates libraries of molecules. The company serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.

HQBoston, MA, US
Employee Ratings4.8

Latest Updates

Employees (est.) (Jan 2021)494(+6%)
Cybersecurity ratingBMore

Key People/Management at Ginkgo Bioworks

Jason Kelly

Jason Kelly

Austin Che

Austin Che

Reshma Shetty

Reshma Shetty

Tom Knight

Tom Knight

Barry Canton

Barry Canton

Show more

Ginkgo Bioworks Office Locations

Ginkgo Bioworks has an office in Boston
Boston, MA, US (HQ)
27 Drydock Ave
Show all (1)

Ginkgo Bioworks Financials and Metrics

Summary Metrics

Founding Date


Ginkgo Bioworks total Funding

$789.1 m

Ginkgo Bioworks latest funding size

$70 m

Time since last funding

8 months ago

Ginkgo Bioworks investors

Ginkgo Bioworks's latest funding round in May 2020 was reported to be $70 m. In total, Ginkgo Bioworks has raised $789.1 m. Ginkgo Bioworks's latest valuation is reported to be $4 b.
View all funding rounds

Ginkgo Bioworks Revenue

Market valuation

Show all financial metrics

Ginkgo Bioworks Acquisitions / Subsidiaries

Company NameDateDeal Size
Gen9January 20, 2017

Ginkgo Bioworks Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Ginkgo Bioworks Online and Social Media Presence

Embed Graph

Ginkgo Bioworks Company Culture

  • CEO Rating



Learn more on Comparably

Ginkgo Bioworks News and Updates

Ginkgo Bioworks Funds Expansion of Rapid Antigen Test Manufacturing with Access Bio in New Jersey

BOSTON, Nov. 20, 2020 /PRNewswire/ -- Today, Ginkgo Bioworks announced it has secured access to at least 10 million rapid antigen test kits from Access Bio, a global in vitro diagnostics company. The tests will be available through Concentric by Ginkgo, the company's end-to-end service...

Bill Gates-Backed Ginkgo Bioworks Has A New $40 Million Spinout Using Synthetic Biology To Clean Wastewater

Last week, Allonnia launched with $40 million in funding to engineer and commercialize microbes to eliminate pollutants in wastewater and soil.

Ginkgo Bioworks Secures Access to SARS-CoV-2 Rapid Antigen Test With Goal of Acquiring and Distributing Up To 50 Million Tests

BOSTON, Oct. 26, 2020 /PRNewswire/ -- Today, Ginkgo Bioworks announced it has secured access to the SD Biosensor rapid antigen test with a goal of acquiring and distributing up to 50 million tests. Concentric by Ginkgo, the company's COVID-19 diagnostic testing service, will begin...

Ginkgo Bioworks CEO on scaling up Covid-19 testing: 'If we try, we can win'

Ginkgo Bioworks, a synthetic biology company, is focusing much of its talent and resources on ramping up Covid-19 testing.

Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment

Today, Ginkgo Bioworks is announcing a $70MM investment from Illumina (Nasdaq: ILMN) and existing Ginkgo investors, General Atlantic and Viking Global Investors. This will enable Ginkgo to build the infrastructure that could enable rapid epidemic response.read more

Synthetic Biology Powerhouse Ginkgo Bioworks Pledges $25 Million In Resources To Projects That Combat Coronavirus

$4.2 billion synthetic biology powerhouse Ginkgo Bioworks is giving $25 million worth of resources in their $400 million R&D facility to public and private teams working to cure, prevent and treat the novel coronavirus.
Show more

Ginkgo Bioworks Blogs

Introducing The Beauty Issue

Grow is Ginkgo’s magazine about synthetic biology. Today, we’re excited to share that our second print edition, The Beauty Issue, has begun shipping! Head over to growbyginkgo.com to order your copy now. Far from your typical beauty magazine, this is a collection of mind-bending essays and stories o…

Solution Engineering at Ginkgo Bioworks

About the Solution Engineering Team Ginkgo’s Solution Engineering team was formed in 2019 as part of the Software Team with the aim of rapidly advancing early stage projects that interface software, biology, and foundries (our biological factories). Ginkgo’s software scrum teams focus on building co…

University Leaders on Testing

As universities slowly begin to reopen, institutions face difficult decisions about when and how to bring students back to campus. But even in this uncharted territory, university leaders are coming up with clever solutions to protect students, staff, and the surrounding community. In partnership wi…

Uncovering a Bug: 10% Inspiration, 90% Perspiration

I’ve got a teammate and friend at Ginkgo, Ray, and I’m sorry to say his condition is, well, it’s not good. … Get it? Get it?! “Ray’s condition, not good” — or rather, “Race condition, not good”?! Well, fine. I’m a software engineer, not a comedian. (To be clear, Ray has nothing to do with […] The po…

Our New Seaport Test Center: Expanding Access to COVID-19 Diagnostic Testing in Boston

Concentric by Ginkgo recently opened its first public test center in Boston’s Seaport District. The new center is expanding access to COVID-19 diagnostic testing for workplaces and organizations of all sizes. Many organizations need employees on-site daily in order to operate. It’s crucial for these…

A Summer Building Infrastructure for Biology

In this blog post, I’ll be discussing my experience as a software engineering intern at Ginkgo, what I’ve worked on, and what I’ve learned. For perspectives from earlier this summer, see this post. How did I learn about Ginkgo? One day last Fall, I came across this video of one of Ginkgo’s founders,…
Show more

Ginkgo Bioworks Frequently Asked Questions

  • When was Ginkgo Bioworks founded?

    Ginkgo Bioworks was founded in 2008.

  • Who are Ginkgo Bioworks key executives?

    Ginkgo Bioworks's key executives are Jason Kelly, Austin Che and Reshma Shetty.

  • How many employees does Ginkgo Bioworks have?

    Ginkgo Bioworks has 494 employees.

  • Who are Ginkgo Bioworks competitors?

    Competitors of Ginkgo Bioworks include SmartZyme, Kiadis Pharma and NovaBay Pharmaceuticals.

  • Where is Ginkgo Bioworks headquarters?

    Ginkgo Bioworks headquarters is located at 27 Drydock Ave, Boston.

  • Where are Ginkgo Bioworks offices?

    Ginkgo Bioworks has an office in Boston.

  • How many offices does Ginkgo Bioworks have?

    Ginkgo Bioworks has 1 office.